Summary:
Randomized, double blinded, placebo controlled, Multi-Center, Parallel-Group, Dose Ranging, study to evaluate the efficacy and safety of 3 doses of CIN-107
Qualified Participants Must:
Age 18 and Over
BMI less than 45
Have a blood pressure reading of at least 130/80
On a stable regimen of 2 or more blood pressure medications (If taking 3 blood pressure medications, one medications must be a diuretic)